-
FDA approves first drug for treatment of peanut allergy for children
2/24/20 Today the U.S. Food and Drug Administration approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to mitigate allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts.
-
Obesity treatment programs may boost kids' self-esteem, body image
2/21/20 Children who participate in obesity treatment programs get a benefit over and above weight loss: they may also start seeing themselves more positively, a new study suggests.
-
Be Prepared to Stay Safe and Healthy in Winter
2/19/20 Although winter comes as no surprise, many of us may not be ready for its arrival. Winter storms and cold temperatures can be dangerous.
-
SchoolSafety.gov Launches to Help Educators, Administrators, Parents, and Law Enforcement Prepare for Threats
2/15/20 The Federal School Safety Clearinghouse website: SchoolSafety.gov. is now active. This website is a one-stop-shop of resources for K-12 administrators, educators, parents, and law enforcement to use to prepare for and address various threats related to safety, security, and support in schools. Learn more.
-
Syringe Reuse and Mishandling of Injectable Medications by Health Care Personnel- Actions for Prevention and Response
2/14/14 February 2020 marks the 10-year anniversary of the Safe Injection Practices Coalition and its One & Only Campaign, a public health effort to eliminate unsafe medical injections. Since 2001, nearly 200,000 patients in the US have been notified of possible exposure to hepatitis B or C virus or HIV because of syringe reuse or mishandling of injectable medications.
-
Rapidly Identify Pediatric Sepsis
2/13/20 Anyone can get an infection, and almost any infection can lead to sepsis. Certain people are at higher risk, including children 12 and younger. Because sepsis begins outside of a hospital in 80% of cases, first responders and pre-hospital caregivers are critical to urgent recognition and treatment of sepsis. Learn more.
-
FDA : MiniMed 600 Series Insulin Pumps by Medtronic : Class I Recall - Due to Incorrect Insulin Dosing
2/12/20 Medtronic is recalling MiniMed 600 Series Insulin Pumps insulin pumps due to a missing or broken retainer ring which helps to lock the insulin cartridge into place in the pump's reservoir compartment. If the cartridge is not locked firmly into place, under or over delivery of insulin may occur, which could result in hypoglycemia or hyperglycemia. Learn more.
